CSL Limited Raised to Buy at Deutsche Bank (CSL)
CSL Limited (ASX:CSL) traded down 0.32% on Thursday, hitting A$74.410. 2,000 shares of the company’s stock traded hands. CSL Limited has a one year low of A$63.770 and a one year high of A$75.130. The stock has a 50-day moving average of A$69.36 and a 200-day moving average of A$69.46. The company has a market cap of A$35.329 billion and a price-to-earnings ratio of 27.74.
A number of other analysts have also recently weighed in on CSL. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Thursday, August 21st. They now have a $74.55 price target on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of A$74.28 ($69.42).
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.